Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Shenni Holdings ROE % Related Terms
Shenni Holdings ROE % Historical Data
* Premium members only.
The historical data trend for Shenni Holdings's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenni Holdings ROE % Chart
Shenni Holdings Annual Data
Trend
Mar23
Mar24
ROE %
-20.17
111.21
Shenni Holdings Semi-Annual Data
Mar23
Sep23
Mar24
Sep24
ROE %
0.00
59.83
125.29
118.04
SNI vs : ROE % Comparison
For the Medical Devices subindustry, Shenni Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenni Holdings ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenni Holdings's ROE % distribution charts can be found below:
* The bar in red indicates where Shenni Holdings's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Sep. 2024) net income data.
ROE % is displayed in the 30-year financial page.
Shenni Holdings (SNI) has a ROE % of 118.04% as of Sep. 2024. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shenni Holdings and its competitors.
Is Shenni Holdings' ROE % too high?
Shenni Holdings' current ROE % is 118.04%. The Medical Devices & Instruments industry median ROE % is 2.42. Shenni Holdings' value of 118.04% is 4777.7% above this industry median.
How does Shenni Holdings' ROE % compare to ?
Shenni Holdings' ROE % of 118.04% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROE % is 2.42. Shenni Holdings' value of 118.04% is 4777.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.42, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenni Holdings's current ROE % of 118.04% is 4777.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shenni Holdings and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenni Holdings's current ROE % is 118.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenni Holdings stock overvalued right now?
Shenni Holdings (SNI) has a current ROE % of 118.04%. The current ROE % is 118.04% and 4777.7% above the Medical Devices & Instruments industry median of 2.42. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Shenni Holdings (SNI), the current ROE % is 118.04% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressBiopharmaceutical Industry Park, South Bridge Yongfeng County, Jiangxi Province, Jian, CHN, 331500
Shenni Holdings Ltd is a holding company. Through its operating subsidiaries in China, it is engaged in the business of the manufacture and distribution of urology medical devices and care products as well as the distribution of cardiovascular and cerebrovascular medical devices. Its products include Guide Wire, Catheter Sheath, and PTA Balloon Catheter. The company derives its revenue from three sources: (i) sales and distribution of urology medical devices (ii) sales and distribution of urology care products, and (iii) sales and distribution of cardiovascular and cerebrovascular medical devices.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNI has been successfully added to your 
